Diarrhoea during checkpoint blockade, not always colitis

Eur J Cancer. 2017 Dec:87:216-218. doi: 10.1016/j.ejca.2017.08.024. Epub 2017 Oct 6.

Authors

Josephine J Koldenhof¹, Karijn P M Suijkerbuijk²

Affiliations

¹ Department of Medical Oncology, B02.2.225, University Medical Center Utrecht Cancer Center, Utrecht University, PO Box 85500, 3508 GA Utrecht, The Netherlands. Electronic address: j.koldenhof@umcutrecht.nl.
² Department of Medical Oncology, Q05.4.300, University Medical Center Utrecht Cancer Center, Utrecht University, PO Box 85500, 3508 GA Utrecht, The Netherlands. Electronic address: K.Suijkerbuijk@umcutrecht.nl.

PMID: 28993041
DOI: 10.1016/j.ejca.2017.08.024

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Colitis / chemically induced*
Diarrhea / chemically induced*
Exocrine Pancreatic Insufficiency / chemically induced*
Female
Humans
Male
Melanoma / drug therapy*
Middle Aged

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
pembrolizumab